CVE-2022-45611
CVE-2022-45611 is a critical-severity vulnerability in Fresenius-kabi Pharmahelp Firmware with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-522.
Key facts
- Severity: Critical (CVSS 3.x base score 9.8)
- EPSS exploit prediction: 1% (57th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-522
- Affected product: Fresenius-kabi Pharmahelp Firmware
- Published:
- Last modified:
Description
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
Frequently asked questions
- What is CVE-2022-45611?
- An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
- How severe is CVE-2022-45611?
- CVE-2022-45611 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
- Is CVE-2022-45611 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (57th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2022-45611?
- CVE-2022-45611 affects Fresenius-kabi Pharmahelp Firmware. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2022-45611?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
- When was CVE-2022-45611 published?
- CVE-2022-45611 was published on 2023-08-22 and last updated on 2026-06-17.
References
- https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder
- https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf
- https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf
Affected products (1)
- cpe:2.3:o:fresenius-kabi:pharmahelp_firmware:5.1.759.0:*:*:*:*:*:*:*
Other CWE-522 (Insufficiently Protected Credentials) vulnerabilities
- CVE-2026-7312 — Critical (CVSS 10.0): CWE‑522: Insufficiently Protected Credentials in web services in Progress Sitefinity version from 14.0.7700 to…
- CVE-2026-29128 — Critical (CVSS 10.0): IDC SFX2100 Satellite Receiver firmware ships with multiple daemon configuration files for routing components (e.g.,…
- CVE-2025-54863 — Critical (CVSS 10.0): Radiometrics VizAir is vulnerable to exposure of the system's REST API key through a publicly accessible configuration…
- CVE-2024-12799 — Critical (CVSS 10.0): Insufficiently Protected Credentials vulnerability in OpenText Identity Manager Advanced Edition on Windows, Linux, 64…
- CVE-2024-51545 — Critical (CVSS 10.0): Username Enumeration vulnerabilities allow access to application level username add, delete, modify and list…
- CVE-2023-1778 — Critical (CVSS 10.0): This vulnerability exists in GajShield Data Security Firewall firmware versions prior to v4.28 (except v4.21) due to…
Browse all CWE-522 (Insufficiently Protected Credentials) vulnerabilities →